Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C
- 31 March 2004
- journal article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 29 (3) , 160-166
- https://doi.org/10.1016/s1386-6532(03)00117-3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999
- Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfectionArchiv für die gesamte Virusforschung, 1997
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis BJournal of Medical Virology, 1995
- Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis BDigestive Diseases and Sciences, 1995
- Inapparent “wild-type” and “e-minus variant” HBV infection in patients with HCV-related chronic hepatitisLiver International, 1994
- Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant womenInfection, 1994
- Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivityJournal of Hepatology, 1993
- Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapyJournal of Hepatology, 1989
- Hepatitis B Virus DNA in Patients with Chronic Liver Disease and Negative Tests for Hepatitis B Surface AntigenNew England Journal of Medicine, 1985